Processa Pharmaceuticals, Inc. PCSA NASDAQ

Processa Pharmaceuticals, Inc. (PCSA) reported total assets of $7.81M and total liabilities of $2.24M for quarter ending 2025-12-31, resulting in total equity of $5.58M.

The company held $5.54M in cash and short-term investments. Total debt stood at $0.00, with net debt of $-5.54M. The Debt-to-Equity (D/E) ratio was 0 (conservative).

Current ratio is 2.54, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0, current ratio of 2.54 — balance sheet is strong
• MOAT (28/100) — Total assets $7.81M and equity $5.58M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 65/100 with 4/7 criteria passed.